Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004383723 | SCV004869516 | uncertain significance | Inborn genetic diseases | 2024-01-24 | criteria provided, single submitter | clinical testing | The c.341T>C (p.L114P) alteration is located in exon 2 (coding exon 2) of the FANCE gene. This alteration results from a T to C substitution at nucleotide position 341, causing the leucine (L) at amino acid position 114 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005038649 | SCV005669085 | uncertain significance | Fanconi anemia complementation group E | 2024-06-03 | criteria provided, single submitter | clinical testing |